22,135,656
Vote Records
28,570
Companies
12,092
Funds
3,981
Managers

Home › Companies › BIOGEN INC. › 2024-2025

BIOGEN INC. 2024-2025 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and BIOGEN INC.’s Form 8-K, filed June 23, 2025 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 13Ballot items
  • 840Asset managers, any item
  • 10,765Fund votes
  • June 17, 2025Meeting date

Results at a glance

Meeting of June 17, 2025: 13 items on BIOGEN INC.’s Form 8-K, filed June 23, 2025: 2 approved · 11 passed (calculated).

Dissent

Significant dissent: 2 directors (22.0%, 21.4% against); 1 say-on-pay vote (67.9% support).

Notable dissent: 5 directors (19.3%, 17.3%, 17.1%, 17.0%, 16.9% against).

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore BIOGEN INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by BIOGEN INC.

These tallies are BIOGEN INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 23, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

BIOGEN INC. — official shareholder meeting results, meeting held June 17, 2025
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Caroline D. Dorsa 90,200,72325,487,099321,364 --10,206,851 78%Passed (calculated)—
Elect Director: Maria C. Freire 96,061,53819,660,536287,112 --10,206,851 83%Passed (calculated)—
Elect Director: William A. Hawkins 96,010,44919,771,738226,999 --10,206,851 83%Passed (calculated)—
Elect Director: Susan K. Langer 96,160,35919,623,542225,285 --10,206,851 83%Passed (calculated)—
Elect Director: Jesus B. Mantas 93,427,72022,348,175233,291 --10,206,851 81%Passed (calculated)—
Elect Director: Lloyd Minor 114,975,935692,399340,852 --10,206,851 99.4%Passed (calculated)—
Elect Director: Menelas Pangalos 114,986,403695,239327,544 --10,206,851 99.4%Passed (calculated)—
Elect Director: Monish Patolawala 115,162,666520,650325,870 --10,206,851 99.5%Passed (calculated)—
Elect Director: Eric K. Rowinsky 91,034,03924,745,219229,928 --10,206,851 79%Passed (calculated)—
Elect Director: Stephen A. Sherwin 95,785,70619,996,175227,305 --10,206,851 83%Passed (calculated)—
Elect Director: Christopher A. Viehbacher 114,893,329883,866231,991 --10,206,851 99.2%Passed (calculated)—
2. The selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025, with the votes cast 120,065,4335,916,416234,188 ---- 95%Approved—
3. Advisory vote on executive compensation, with the votes cast 78,531,75637,113,368364,062 --10,206,851 68%Approved—

Source: BIOGEN INC., Form 8-K, filed with the SEC on June 23, 2025 — read the filing on EDGAR.

How asset managers voted at the BIOGEN INC. 2024-2025 meeting

840 asset managers disclosed a vote on at least one BIOGEN INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.

Elect Director: Caroline D. Dorsa

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 7 wordings of this item as funds reported it.

78% Majority: yes · of votes cast

FOR 78%AGAINST
FOR: 90,200,723AGAINST: 25,487,099

Prior year: 73.6% for (June 20, 2024 meeting) ▲ 4.4 pts

Details: description as filed, official tally, votes by 150 asset managers

Description as filed by funds: Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: Caroline D. Dorsa

BIOGEN INC.’s own tally for this item (“Elect Director: Caroline D. Dorsa”): 90,200,723 for, 25,487,099 against, per its Form 8-K filed June 23, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 78% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 150 asset managers below reported 45,408,735 for, 16,209,323 against, 36,884 abstained, 12,400 not voted.

FORAGAINST
FOR: 45,408,735AGAINST: 16,209,323ABSTAIN: 36,884NOT VOTED: 12,400
Largest asset managers voting on “Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of” at BIOGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard20,894,73112,957,299 00Mixed
BlackRock5,399,0160 00For
Fidelity4,688,9810 00For
State Street2,424,34180 00For
PRIMECAP Odyssey Funds02,064,099 00Against
T. Rowe Price1,405,891546,159 00Mixed
Invesco1,452,0700 00For
Pacer Funds Trust1,284,9680 00For
Charles Schwab997,1130 00For
First Trust816,5900 00For
MFS554,5450 00For
Jackson National496,181871 00For
JPMorgan0374,925 00Against
TIAA283,0010 00For
ProShares270,3980 00For
Dimensional269,8570 00For
Advisor Managed Portfolios258,0370 00For
MASTER INVESTMENT PORTFOLIO250,0430 00For
Prudential/PGIM239,4403 00For
Bridge Builder Trust116,959100,459 00Mixed
Transamerica199,715861 00For
AQR159,8820 00For
MassMutual130,839417 00For
FRANKLIN STRATEGIC SERIES129,3440 00For
Global X126,7750 00For

Showing the 25 largest of 150 asset managers. All 150 are in the interactive database (link above).

Elect Director: Christopher A. Viehbacher

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 8 wordings of this item as funds reported it.

99.2% Majority: yes · of votes cast

FOR 99.2%
FOR: 114,893,329AGAINST: 883,866

Prior year: 99.3% for (June 20, 2024 meeting) unchanged

Details: description as filed, official tally, votes by 150 asset managers

Description as filed by funds: Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: Christopher A. Viehbacher

BIOGEN INC.’s own tally for this item (“Elect Director: Christopher A. Viehbacher”): 114,893,329 for, 883,866 against, per its Form 8-K filed June 23, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.2% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 150 asset managers below reported 61,612,837 for, 5,224 against, 36,881 abstained, 12,400 not voted.

FOR
FOR: 61,612,837AGAINST: 5,224ABSTAIN: 36,881NOT VOTED: 12,400
Largest asset managers voting on “Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of” at BIOGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard33,852,0300 00For
BlackRock5,399,0160 00For
Fidelity4,688,9810 00For
State Street2,424,39328 00For
PRIMECAP Odyssey Funds2,064,0990 00For
T. Rowe Price1,952,0500 00For
Invesco1,452,0700 00For
Pacer Funds Trust1,284,9680 00For
Charles Schwab997,1130 00For
First Trust816,5900 00For
MFS554,5450 00For
Jackson National497,0520 00For
JPMorgan374,9250 00For
TIAA283,0010 00For
ProShares270,3980 00For
Dimensional269,8570 00For
Advisor Managed Portfolios258,0370 00For
MASTER INVESTMENT PORTFOLIO250,0430 00For
Prudential/PGIM239,4430 00For
Bridge Builder Trust217,4180 00For
Transamerica200,5760 00For
AQR159,8820 00For
MassMutual131,2560 00For
FRANKLIN STRATEGIC SERIES129,3440 00For
Global X126,7750 00For

Showing the 25 largest of 150 asset managers. All 150 are in the interactive database (link above).

Elect Director: Eric K. Rowinsky

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 8 wordings of this item as funds reported it.

79% Majority: yes · of votes cast

FOR 79%AGAINST
FOR: 91,034,039AGAINST: 24,745,219

Prior year: 80.8% for (June 20, 2024 meeting) ▼ 2.2 pts

Details: description as filed, official tally, votes by 150 asset managers

Description as filed by funds: Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: Eric K. Rowinsky

BIOGEN INC.’s own tally for this item (“Elect Director: Eric K. Rowinsky”): 91,034,039 for, 24,745,219 against, per its Form 8-K filed June 23, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 79% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 150 asset managers below reported 45,864,978 for, 15,753,083 against, 36,881 abstained, 12,400 not voted.

FORAGAINST
FOR: 45,864,978AGAINST: 15,753,083ABSTAIN: 36,881NOT VOTED: 12,400
Largest asset managers voting on “Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of” at BIOGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard20,892,70612,959,324 00Mixed
BlackRock5,398,075941 00For
Fidelity4,688,9810 00For
State Street2,424,34180 00For
PRIMECAP Odyssey Funds02,064,099 00Against
T. Rowe Price1,405,891546,159 00Mixed
Invesco1,452,0700 00For
Pacer Funds Trust1,284,9680 00For
Charles Schwab997,1130 00For
First Trust816,5900 00For
MFS554,5450 00For
Jackson National497,0520 00For
JPMorgan374,9250 00For
TIAA283,0010 00For
ProShares270,3980 00For
Dimensional269,8570 00For
Advisor Managed Portfolios258,0370 00For
MASTER INVESTMENT PORTFOLIO250,0430 00For
Prudential/PGIM239,4430 00For
Bridge Builder Trust116,959100,459 00Mixed
Transamerica200,5760 00For
AQR159,8820 00For
MassMutual130,839417 00For
FRANKLIN STRATEGIC SERIES129,3440 00For
Global X119,1427,633 00Mixed

Showing the 25 largest of 150 asset managers. All 150 are in the interactive database (link above).

Elect Director: Jesus B. Mantas

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 8 wordings of this item as funds reported it.

81% Majority: yes · of votes cast

FOR 81%AGAINST
FOR: 93,427,720AGAINST: 22,348,175

Prior year: 83.4% for (June 20, 2024 meeting) ▼ 2.7 pts

Details: description as filed, official tally, votes by 150 asset managers

Description as filed by funds: Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: Jesus B. Mantas

BIOGEN INC.’s own tally for this item (“Elect Director: Jesus B. Mantas”): 93,427,720 for, 22,348,175 against, per its Form 8-K filed June 23, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 81% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 150 asset managers below reported 45,900,629 for, 15,714,481 against, 39,833 abstained, 12,400 not voted.

FORAGAINST
FOR: 45,900,629AGAINST: 15,714,481ABSTAIN: 39,833NOT VOTED: 12,400
Largest asset managers voting on “Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of” at BIOGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard20,894,73212,957,298 00Mixed
BlackRock5,399,0160 00For
Fidelity4,688,9810 00For
State Street2,424,4210 00For
PRIMECAP Odyssey Funds02,064,099 00Against
T. Rowe Price1,405,891546,159 00Mixed
Invesco1,452,0700 00For
Pacer Funds Trust1,284,9680 00For
Charles Schwab997,1130 00For
First Trust816,5900 00For
MFS554,5450 00For
Jackson National497,0520 00For
JPMorgan374,9250 00For
TIAA283,0010 00For
ProShares270,3980 00For
Dimensional269,8570 00For
Advisor Managed Portfolios258,0370 00For
MASTER INVESTMENT PORTFOLIO250,0430 00For
Prudential/PGIM239,4430 00For
Bridge Builder Trust138,69778,721 00Mixed
Transamerica200,5760 00For
AQR159,8820 00For
MassMutual130,839417 00For
FRANKLIN STRATEGIC SERIES129,3440 00For
Global X126,7750 00For

Showing the 25 largest of 150 asset managers. All 150 are in the interactive database (link above).

Elect Director: Lloyd Minor

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 8 wordings of this item as funds reported it.

99.4% Majority: yes · of votes cast

FOR 99.4%
FOR: 114,975,935AGAINST: 692,399
Details: description as filed, official tally, votes by 150 asset managers

Description as filed by funds: Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: Lloyd Minor

BIOGEN INC.’s own tally for this item (“Elect Director: Lloyd Minor”): 114,975,935 for, 692,399 against, per its Form 8-K filed June 23, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.4% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 150 asset managers below reported 61,612,868 for, 5,189 against, 36,885 abstained, 12,400 not voted.

FOR
FOR: 61,612,868AGAINST: 5,189ABSTAIN: 36,885NOT VOTED: 12,400
Largest asset managers voting on “Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of” at BIOGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard33,852,0300 00For
BlackRock5,399,0160 00For
Fidelity4,688,9810 00For
State Street2,424,4210 00For
PRIMECAP Odyssey Funds2,064,0990 00For
T. Rowe Price1,952,0500 00For
Invesco1,452,0700 00For
Pacer Funds Trust1,284,9680 00For
Charles Schwab997,1130 00For
First Trust816,5900 00For
MFS554,5450 00For
Jackson National497,0520 00For
JPMorgan374,9250 00For
TIAA283,0010 00For
ProShares270,3980 00For
Dimensional269,8570 00For
Advisor Managed Portfolios258,0370 00For
MASTER INVESTMENT PORTFOLIO250,0430 00For
Prudential/PGIM239,4430 00For
Bridge Builder Trust217,4180 00For
Transamerica200,5760 00For
AQR159,8820 00For
MassMutual131,2560 00For
FRANKLIN STRATEGIC SERIES129,3440 00For
Global X126,7750 00For

Showing the 25 largest of 150 asset managers. All 150 are in the interactive database (link above).

Elect Director: Maria C. Freire

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 8 wordings of this item as funds reported it.

83% Majority: yes · of votes cast

FOR 83%AGAINST
FOR: 96,061,538AGAINST: 19,660,536

Prior year: 84.3% for (June 20, 2024 meeting) ▼ 1.3 pts

Details: description as filed, official tally, votes by 150 asset managers

Description as filed by funds: Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: Maria C. Freire

BIOGEN INC.’s own tally for this item (“Elect Director: Maria C. Freire”): 96,061,538 for, 19,660,536 against, per its Form 8-K filed June 23, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 83% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 150 asset managers below reported 46,562,280 for, 15,055,779 against, 36,883 abstained, 12,400 not voted.

FORAGAINST
FOR: 46,562,280AGAINST: 15,055,779ABSTAIN: 36,883NOT VOTED: 12,400
Largest asset managers voting on “Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of” at BIOGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard20,894,73212,957,298 00Mixed
BlackRock5,399,0160 00For
Fidelity4,688,9810 00For
State Street2,424,4210 00For
PRIMECAP Odyssey Funds02,064,099 00Against
T. Rowe Price1,952,0500 00For
Invesco1,452,0700 00For
Pacer Funds Trust1,284,9680 00For
Charles Schwab997,1130 00For
First Trust816,5900 00For
MFS554,5450 00For
Jackson National497,0520 00For
JPMorgan374,9250 00For
TIAA283,0010 00For
ProShares270,3980 00For
Dimensional269,8570 00For
Advisor Managed Portfolios258,0370 00For
MASTER INVESTMENT PORTFOLIO250,0430 00For
Prudential/PGIM239,4403 00For
Bridge Builder Trust195,68021,738 00Mixed
Transamerica199,715861 00For
AQR159,8820 00For
MassMutual131,2560 00For
FRANKLIN STRATEGIC SERIES129,3440 00For
Global X126,7750 00For

Showing the 25 largest of 150 asset managers. All 150 are in the interactive database (link above).

Elect Director: Menelas Pangalos

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 8 wordings of this item as funds reported it.

99.4% Majority: yes · of votes cast

FOR 99.4%
FOR: 114,986,403AGAINST: 695,239
Details: description as filed, official tally, votes by 150 asset managers

Description as filed by funds: Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: Menelas Pangalos

BIOGEN INC.’s own tally for this item (“Elect Director: Menelas Pangalos”): 114,986,403 for, 695,239 against, per its Form 8-K filed June 23, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.4% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 150 asset managers below reported 61,612,868 for, 5,190 against, 36,884 abstained, 12,400 not voted.

FOR
FOR: 61,612,868AGAINST: 5,190ABSTAIN: 36,884NOT VOTED: 12,400
Largest asset managers voting on “Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of” at BIOGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard33,852,0300 00For
BlackRock5,399,0160 00For
Fidelity4,688,9810 00For
State Street2,424,4210 00For
PRIMECAP Odyssey Funds2,064,0990 00For
T. Rowe Price1,952,0500 00For
Invesco1,452,0700 00For
Pacer Funds Trust1,284,9680 00For
Charles Schwab997,1130 00For
First Trust816,5900 00For
MFS554,5450 00For
Jackson National497,0520 00For
JPMorgan374,9250 00For
TIAA283,0010 00For
ProShares270,3980 00For
Dimensional269,8570 00For
Advisor Managed Portfolios258,0370 00For
MASTER INVESTMENT PORTFOLIO250,0430 00For
Prudential/PGIM239,4430 00For
Bridge Builder Trust217,4180 00For
Transamerica200,5760 00For
AQR159,8820 00For
MassMutual131,2560 00For
FRANKLIN STRATEGIC SERIES129,3440 00For
Global X126,7750 00For

Showing the 25 largest of 150 asset managers. All 150 are in the interactive database (link above).

Elect Director: Monish Patolawala

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 8 wordings of this item as funds reported it.

99.5% Majority: yes · of votes cast

FOR 99.5%
FOR: 115,162,666AGAINST: 520,650

Prior year: 99.7% for (June 20, 2024 meeting) ▼ 0.1 pts

Details: description as filed, official tally, votes by 150 asset managers

Description as filed by funds: Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: Monish Patolawala

BIOGEN INC.’s own tally for this item (“Elect Director: Monish Patolawala”): 115,162,666 for, 520,650 against, per its Form 8-K filed June 23, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 150 asset managers below reported 61,612,874 for, 5,183 against, 36,884 abstained, 12,400 not voted.

FOR
FOR: 61,612,874AGAINST: 5,183ABSTAIN: 36,884NOT VOTED: 12,400
Largest asset managers voting on “Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of” at BIOGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard33,852,0300 00For
BlackRock5,399,0160 00For
Fidelity4,688,9810 00For
State Street2,424,4210 00For
PRIMECAP Odyssey Funds2,064,0990 00For
T. Rowe Price1,952,0500 00For
Invesco1,452,0700 00For
Pacer Funds Trust1,284,9680 00For
Charles Schwab997,1130 00For
First Trust816,5900 00For
MFS554,5450 00For
Jackson National497,0520 00For
JPMorgan374,9250 00For
TIAA283,0010 00For
ProShares270,3980 00For
Dimensional269,8570 00For
Advisor Managed Portfolios258,0370 00For
MASTER INVESTMENT PORTFOLIO250,0430 00For
Prudential/PGIM239,4430 00For
Bridge Builder Trust217,4180 00For
Transamerica200,5760 00For
AQR159,8820 00For
MassMutual131,2560 00For
FRANKLIN STRATEGIC SERIES129,3440 00For
Global X126,7750 00For

Showing the 25 largest of 150 asset managers. All 150 are in the interactive database (link above).

Elect Director: Stephen A. Sherwin

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 8 wordings of this item as funds reported it.

83% Majority: yes · of votes cast

FOR 83%AGAINST
FOR: 95,785,706AGAINST: 19,996,175

Prior year: 84.7% for (June 20, 2024 meeting) ▼ 1.9 pts

Details: description as filed, official tally, votes by 150 asset managers

Description as filed by funds: Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: Stephen A. Sherwin

BIOGEN INC.’s own tally for this item (“Elect Director: Stephen A. Sherwin”): 95,785,706 for, 19,996,175 against, per its Form 8-K filed June 23, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 83% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 150 asset managers below reported 46,563,476 for, 15,054,585 against, 36,881 abstained, 12,400 not voted.

FORAGAINST
FOR: 46,563,476AGAINST: 15,054,585ABSTAIN: 36,881NOT VOTED: 12,400
Largest asset managers voting on “Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of” at BIOGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard20,894,73212,957,298 00Mixed
BlackRock5,399,0160 00For
Fidelity4,688,9810 00For
State Street2,424,34180 00For
PRIMECAP Odyssey Funds02,064,099 00Against
T. Rowe Price1,952,0500 00For
Invesco1,452,0700 00For
Pacer Funds Trust1,284,9680 00For
Charles Schwab997,1130 00For
First Trust816,5900 00For
MFS554,5450 00For
Jackson National497,0520 00For
JPMorgan374,9250 00For
TIAA283,0010 00For
ProShares270,3980 00For
Dimensional269,8570 00For
Advisor Managed Portfolios258,0370 00For
MASTER INVESTMENT PORTFOLIO250,0430 00For
Prudential/PGIM239,4403 00For
Bridge Builder Trust195,68021,738 00Mixed
Transamerica199,715861 00For
AQR159,8820 00For
MassMutual131,2560 00For
FRANKLIN STRATEGIC SERIES129,3440 00For
Global X126,7750 00For

Showing the 25 largest of 150 asset managers. All 150 are in the interactive database (link above).

Elect Director: Susan K. Langer

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 8 wordings of this item as funds reported it.

83% Majority: yes · of votes cast

FOR 83%AGAINST
FOR: 96,160,359AGAINST: 19,623,542

Prior year: 77.5% for (June 20, 2024 meeting) ▲ 5.5 pts

Details: description as filed, official tally, votes by 150 asset managers

Description as filed by funds: Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: Susan K. Langer

BIOGEN INC.’s own tally for this item (“Elect Director: Susan K. Langer”): 96,160,359 for, 19,623,542 against, per its Form 8-K filed June 23, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 83% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 150 asset managers below reported 45,532,942 for, 16,085,119 against, 36,881 abstained, 12,400 not voted.

FORAGAINST
FOR: 45,532,942AGAINST: 16,085,119ABSTAIN: 36,881NOT VOTED: 12,400
Largest asset managers voting on “Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of” at BIOGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard20,894,73212,957,298 00Mixed
BlackRock5,399,0160 00For
Fidelity4,688,9810 00For
State Street2,424,4210 00For
PRIMECAP Odyssey Funds02,064,099 00Against
T. Rowe Price1,405,891546,159 00Mixed
Invesco1,452,0700 00For
Pacer Funds Trust1,284,9680 00For
Charles Schwab997,1130 00For
First Trust816,5900 00For
MFS554,5450 00For
Jackson National496,181871 00For
JPMorgan0374,925 00Against
TIAA283,0010 00For
ProShares270,3980 00For
Dimensional269,8570 00For
Advisor Managed Portfolios258,0370 00For
MASTER INVESTMENT PORTFOLIO250,0430 00For
Prudential/PGIM239,4430 00For
Bridge Builder Trust138,69778,721 00Mixed
Transamerica200,5760 00For
AQR159,8820 00For
MassMutual130,839417 00For
FRANKLIN STRATEGIC SERIES129,3440 00For
Global X126,7750 00For

Showing the 25 largest of 150 asset managers. All 150 are in the interactive database (link above).

Elect Director: William A. Hawkins

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 8 wordings of this item as funds reported it.

83% Majority: yes · of votes cast

FOR 83%AGAINST
FOR: 96,010,449AGAINST: 19,771,738

Prior year: 80.3% for (June 20, 2024 meeting) ▲ 2.6 pts

Details: description as filed, official tally, votes by 150 asset managers

Description as filed by funds: Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2026 annual meeting of stockholders and their successors are duly elected and qualified: William A. Hawkins

BIOGEN INC.’s own tally for this item (“Elect Director: William A. Hawkins”): 96,010,449 for, 19,771,738 against, per its Form 8-K filed June 23, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 83% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 150 asset managers below reported 46,551,796 for, 15,066,265 against, 36,881 abstained, 12,400 not voted.

FORAGAINST
FOR: 46,551,796AGAINST: 15,066,265ABSTAIN: 36,881NOT VOTED: 12,400
Largest asset managers voting on “Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement to our Board of” at BIOGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard20,892,70712,959,323 00Mixed
BlackRock5,398,075941 00For
Fidelity4,688,9810 00For
State Street2,424,4210 00For
PRIMECAP Odyssey Funds02,064,099 00Against
T. Rowe Price1,952,0500 00For
Invesco1,452,0700 00For
Pacer Funds Trust1,284,9680 00For
Charles Schwab997,1130 00For
First Trust816,5900 00For
MFS554,5450 00For
Jackson National497,0520 00For
JPMorgan374,9250 00For
TIAA283,0010 00For
ProShares270,3980 00For
Dimensional269,8570 00For
Advisor Managed Portfolios258,0370 00For
MASTER INVESTMENT PORTFOLIO250,0430 00For
Prudential/PGIM239,4403 00For
Bridge Builder Trust195,68021,738 00Mixed
Transamerica199,715861 00For
AQR159,8820 00For
MassMutual131,2560 00For
FRANKLIN STRATEGIC SERIES129,3440 00For
Global X119,1427,633 00Mixed

Showing the 25 largest of 150 asset managers. All 150 are in the interactive database (link above).

Advisory vote on executive compensation, with the votes cast

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 7 wordings of this item as funds reported it.

68% Approved · of votes cast

FOR 68%AGAINST
FOR: 78,531,756AGAINST: 37,113,368

Prior year: 95.8% for (June 20, 2024 meeting) ▼ 27.9 pts

Details: description as filed, official tally, votes by 792 asset managers

Description as filed by funds: Say on Pay - To hold an advisory vote on executive compensation.

BIOGEN INC.’s own tally for this item (“3. The advisory vote on executive compensation, with the votes cast”): 78,531,756 for, 37,113,368 against — passed, per its Form 8-K filed June 23, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Stockholders approved the advisory vote on executive compensation, with the votes cast as follows:”
Support: 68% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of BIOGEN INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Advisory Vote to Ratify Named Executive Officers' Compensation” (35 managers, Fund and manager reports combined; may count the same shares twice; no share total shown); “14A Executive Compensation” (13 managers, 12,831 for, 2,695 against).

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 141 asset managers voting on “Say on Pay - To hold an advisory vote on executive compensation.” at BIOGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard33,796,63855,392 00For
BlackRock4,908,722490,294 00Mixed
Fidelity4,639,58149,400 00For
State Street2,419,4934,928 00For
PRIMECAP Odyssey Funds2,064,0990 00For
T. Rowe Price1,405,891546,159 00Mixed
Invesco1,452,0700 00For
Pacer Funds Trust1,284,9680 00For
Charles Schwab0997,113 00Against
First Trust0816,590 00Against
MFS0554,545 00Against
Jackson National225,995271,057 00Mixed
JPMorgan374,9250 00For
TIAA0283,001 00Against
ProShares0270,398 00Against
Dimensional0269,857 00Against
Advisor Managed Portfolios8,037250,000 00Against
MASTER INVESTMENT PORTFOLIO235,89414,149 00Mixed
Prudential/PGIM234,0405,403 00For
Bridge Builder Trust116,959100,459 00Mixed
Transamerica3,442197,134 00Against
AQR0159,882 00Against
MassMutual124,3116,945 00Mixed
FRANKLIN STRATEGIC SERIES0129,344 00Against
Global X126,7750 00For

Fund voting reports, all 141 managers: 54,367,676 for, 7,080,110 against, 36,885 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 679 asset managers voting on “Say on Pay - To hold an advisory vote on executive compensation.” at BIOGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
PRIMECAP MANAGEMENT CO/CA/15,477,9410 00For
BlackRock5,028,6501,753,855 00Mixed
State Street4,763,961114,363 00For
Wellington4,643,9300 00For
GEODE CAPITAL MANAGEMENT, LLC3,843,3400 00For
T. Rowe Price2,437,1861,144,439 00Mixed
Invesco2,013,9090 00For
Amundi01,806,751 00Against
Fidelity1,260,470226,000 00Mixed
Northern Trust01,226,988 00Against
Two Sigma01,169,699 00Against
Charles Schwab01,021,035 00Against
Vanguard918,79715,716 00For
UBS0855,003 00Against
DE Shaw0822,563 00Against
Legal & General Investment Management Ltd15,837794,372 00Against
MELLON INVESTMENTS Corp0785,359 00Against
MASSACHUSETTS FINANCIAL SERVICES CO /MA/0773,775 00Against
Point720741,149 00Against
PARAMETRIC PORTFOLIO ASSOCIATES LLC0636,488 00Against
AQR0571,592 00Against
FRANKLIN ADVISERS INC0482,858 00Against
AVIVA INVESTORS GLOBAL SERVICES LTD0469,889 00Against
AustralianSuper Pty Ltd0409,110 00Against
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM0382,488 00Against

Institutional-manager reports, all 679 managers: 44,351,976 for, 26,256,785 against, 527 abstained, 313,959 not voted. Showing the 25 largest; every one is in the interactive database (link above).

The selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the…

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 6 wordings of this item as funds reported it.

95% Approved · of votes cast

FOR 95%
FOR: 120,065,433AGAINST: 5,916,416

Prior year: 95.9% for (June 20, 2024 meeting) ▼ 0.6 pts

Details: description as filed, official tally, votes by 147 asset managers

Description as filed by funds: To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year ending December 31, 2025

BIOGEN INC.’s own tally for this item (“2. The selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025, with the votes cast”): 120,065,433 for, 5,916,416 against — passed, per its Form 8-K filed June 23, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Stockholders ratified the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025, with the votes cast as follows:”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of BIOGEN INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Ratify Appointment of Independent Auditors” (4 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).

The 147 asset managers below reported 61,532,223 for, 48,035 against, 36,880 abstained.

FOR
FOR: 61,532,223AGAINST: 48,035ABSTAIN: 36,880
Largest asset managers voting on “To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for” at BIOGEN INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard33,850,0032,027 00For
BlackRock5,399,0160 00For
Fidelity4,688,9810 00For
State Street2,424,34180 00For
PRIMECAP Odyssey Funds2,064,0990 00For
T. Rowe Price1,952,0500 00For
Invesco1,452,0700 00For
Pacer Funds Trust1,284,9680 00For
Charles Schwab997,1130 00For
First Trust816,5900 00For
MFS554,5450 00For
Jackson National497,0520 00For
JPMorgan374,9250 00For
TIAA283,0010 00For
ProShares270,3980 00For
Dimensional269,8570 00For
Advisor Managed Portfolios258,0370 00For
MASTER INVESTMENT PORTFOLIO250,0430 00For
Prudential/PGIM239,4430 00For
Bridge Builder Trust217,4180 00For
Transamerica200,5760 00For
AQR159,8820 00For
MassMutual131,2560 00For
FRANKLIN STRATEGIC SERIES129,3440 00For
Global X126,7750 00For

Showing the 25 largest of 147 asset managers. All 147 are in the interactive database (link above).

Not shown here: this season’s fund filings also report 1 item from the meeting of June 20, 2024, which belongs to the 2023-2024 season. A meeting outside this season’s July 1 to June 30 window is not counted in this page’s items or in its totals of asset managers and fund votes.

Largest BIOGEN INC. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 145,800,000 shares outstanding at the time of that meeting.

Fund voting reports: top BIOGEN INC. shareholders by shares voted on “Election of Directors. To elect the 11 nominees identified in the accompanying Proxy Statement…”, 2024-2025
#Asset manager % of shares outstanding
1Vanguard 23.22%
2BlackRock 3.70%
3Fidelity 3.22%
4State Street 1.66%
5PRIMECAP Odyssey Funds 1.42%
6T. Rowe Price 1.34%
7Invesco 1.00%
8Pacer Funds Trust 0.88%
9Charles Schwab 0.68%
10First Trust 0.56%
Institutional-manager reports: top BIOGEN INC. shareholders by shares voted on “Say on Pay - To hold an advisory vote on executive compensation.”, 2024-2025
#Asset manager % of shares outstanding
1PRIMECAP MANAGEMENT CO/CA/ 10.62%
2BlackRock 4.65%
3State Street 3.35%
4Wellington 3.19%
5GEODE CAPITAL MANAGEMENT, LLC 2.64%
6T. Rowe Price 2.46%
7Invesco 1.38%
8Amundi 1.24%
9Fidelity 1.02%
10Northern Trust 0.84%

Reported BIOGEN INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

BIOGEN INC. holdings and ownership disclosed for the 2024-2025 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
FMR LLC16,652,975 11.42%Schedule 13G, filed June 5, 2026
BlackRock15,211,036 10.43%Form 13F, quarter ended March 31, 2025
PRIMECAP MANAGEMENT CO/CA/14,954,697 10.26%Schedule 13G, filed November 13, 2025
State Street7,396,910 5.07%Form 13F, quarter ended March 31, 2025
Wellington Management4,672,437 3.20%Form 13F, quarter ended March 31, 2025
Invesco2,265,007 1.55%Form 13F, quarter ended March 31, 2025
Morgan Stanley1,990,668 1.37%Form 13F, quarter ended March 31, 2025
Citadel Advisors1,746,264 1.20%Form 13F, quarter ended March 31, 2025
D.E. Shaw1,726,372 1.18%Form 13F, quarter ended March 31, 2025
Norges Bank1,523,141 1.04%Form 13F, quarter ended March 31, 2025

Percentages above are of 145,800,000 shares outstanding, as reported by BIOGEN INC. on its Form 10-K dated December 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At BIOGEN INC.'s shareholder meeting held June 17, 2025, in the 2024-2025 proxy season, 840 asset managers reported votes on at least one of its 13 ballot items in their SEC Form N-PX filings, covering 10,765 separate fund positions. On the most widely held item on that ballot — Say on Pay - To hold an advisory vote on executive compensation. — BIOGEN INC.'s filing reports the proposal as approved, with 68% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: BIOGEN INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 23, 2025.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from BIOGEN INC.’s 10-K dated December 31, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

BIOGEN INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.

Cite this page

Proxy Votes Now, “BIOGEN (BIIB) 2025 Annual Meeting: Vote Results & How Funds Voted”, https://proxyvotesnow.com/company/biogen-inc/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.